Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


01.11.2021

1 AJR Am J Roentgenol
3 Aliment Pharmacol Ther
3 Am J Gastroenterol
2 BMC Gastroenterol
1 Clin Gastroenterol Hepatol
1 Eur J Gastroenterol Hepatol
1 Gastroenterol Hepatol
2 Gastroenterology
1 Gut
3 J Clin Gastroenterol
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Scand J Gastroenterol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. ANUPINDI SA, Kim MJ, Kljucevsek D, Watson TA, et al
    The Global Reading Room: Imaging of Suspected Pediatric Crohn Disease.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26977.
    PubMed        


    Aliment Pharmacol Ther

  2. CHAO K, Huang Y, Zhu X, Tang J, et al
    Randomised clinical trial: dose optimising strategy by NUDT15 genotyping reduces leucopenia during thiopurine treatment of Crohn's disease.
    Aliment Pharmacol Ther. 2021;54:1124-1133.
    PubMed         Abstract available

  3. BURISCH J, Lophaven S, Munkholm P, Langholz E, et al
    Surgery, cancer and mortality among patients with ulcerative colitis diagnosed 1962-1987 and followed until 2017 in a Danish population-based inception cohort.
    Aliment Pharmacol Ther. 2021 Oct 29. doi: 10.1111/apt.16677.
    PubMed         Abstract available

  4. BEZZIO C, Armuzzi A, Furfaro F, Ardizzone S, et al
    Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Aliment Pharmacol Ther. 2021 Oct 25. doi: 10.1111/apt.16663.
    PubMed         Abstract available


    Am J Gastroenterol

  5. DULAI PS, Jairath V, Narula N, Wong E, et al
    A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease.
    Am J Gastroenterol. 2021;116:1709-1719.
    PubMed         Abstract available

  6. ASHHAB AA, Lee M, Melmed GY
    Extensive Upper Gastrointestinal Fistulization in Crohn's Disease, an Uncommon Cause for a Common Presentation.
    Am J Gastroenterol. 2021;116:1978.
    PubMed        

  7. LAUBE R, Tran Y, Paramsothy S, Leong RW, et al
    Assisted Reproductive Technology in Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2021 Oct 25. pii: 00000434-990000000-00131.
    PubMed         Abstract available


    BMC Gastroenterol

  8. KIM D, Jung JY, Oh HS, Jee SR, et al
    Comparison of sampling methods in assessing the microbiome from patients with ulcerative colitis.
    BMC Gastroenterol. 2021;21:396.
    PubMed         Abstract available

  9. LEE JY, Oh K, Hong HS, Kim K, et al
    Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea.
    BMC Gastroenterol. 2021;21:390.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  10. LUKIN DJ, Funez-dePagnier G, Lima S, Lai D, et al
    No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD.
    Clin Gastroenterol Hepatol. 2021;19:2312-2314.
    PubMed        


    Eur J Gastroenterol Hepatol

  11. SHAMSEYA AM, Hussein WM, Elnely DA, Adel F, et al
    Serum matrix metalloproteinase-9 concentration as a marker of disease activity in patients with inflammatory bowel disease.
    Eur J Gastroenterol Hepatol. 2021 Oct 20. pii: 00042737-900000000-97135.
    PubMed         Abstract available


    Gastroenterol Hepatol

  12. BLASCO PATINO F, Nicolae MV, Navarro E
    Acute submandibular sialadenitis in a patient with Crohn's disease being treated with infliximab.
    Gastroenterol Hepatol. 2021;44:49-50.
    PubMed        


    Gastroenterology

  13. RODRIGUEZ-PALACIOS A, Basson AR, Cominelli F
    Artificial Sweeteners and Whole-Food Science: Could Mice Help Clinicians Make Diet Recommendations for IBD Patients?
    Gastroenterology. 2021;161:8-14.
    PubMed        

  14. DE A, Chen W, Li H, Wright JR, et al
    Bacterial Swarmers Enriched During Intestinal Stress Ameliorate Damage.
    Gastroenterology. 2021;161:211-224.
    PubMed         Abstract available


    Gut

  15. ODUFALU FD, Long M, Lin K, Mahadevan U, et al
    Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry.
    Gut. 2021 Oct 22. pii: gutjnl-2021-325317. doi: 10.1136/gutjnl-2021-325317.
    PubMed         Abstract available


    J Clin Gastroenterol

  16. LIPCSEY M, Stein DJ, DeVore ZG, Feuerstein JD, et al
    Rising Rate of Obesity in Patients Admitted for Crohn's Disease Increases Costs But Not Mortality.
    J Clin Gastroenterol. 2021;55:716-720.
    PubMed         Abstract available

  17. TUNIO NA, Mansoor E, Sheriff MZ, Cooper GS, et al
    Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National Study.
    J Clin Gastroenterol. 2020 Oct 16. doi: 10.1097/MCG.0000000000001449.
    PubMed         Abstract available

  18. DAI C, Huang YH
    Biological Therapy in Chronic Antibiotic Refractory Pouchitis.
    J Clin Gastroenterol. 2021;55:911.
    PubMed        


    PLoS One

  19. MEI Z, Feng Q, Du P, Li B, et al
    Surgical treatment for cryptoglandular and Crohn's perianal fistulas: Protocol of an umbrella review.
    PLoS One. 2021;16:e0251460.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  20. CHEN G, Wang F, Nie M, Zhang H, et al
    Roe-inspired stem cell microcapsules for inflammatory bowel disease treatment.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Scand J Gastroenterol

  21. LINDHAGEN S, Karling P
    A more frequent disease monitorering but no increased disease activity in patients with inflammatory bowel disease during the first year of the SARS-CoV-2 pandemic. A retrospective study.
    Scand J Gastroenterol. 2021 Oct 26:1-6. doi: 10.1080/00365521.2021.1993328.
    PubMed         Abstract available

  22. ATTAUABI M, Hoglund C, Fassov J, Pedersen KB, et al
    Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases.
    Scand J Gastroenterol. 2021;56:1040-1048.
    PubMed         Abstract available

  23. JORISSEN C, Verstockt B, Schils N, Sabino J, et al
    Long-term clinical outcome after thiopurine discontinuation in elderly IBD patients.
    Scand J Gastroenterol. 2021;56:1323-1327.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: